Hritvik Jain, Andrew M. Goldsweig/LinkedIn
Oct 29, 2025, 07:09
Hritvik Jain and Andrew Goldsweig Shared Risk About the Risk of MACCE, AMI, and readmission in IBD patients undergoing PCI
Hritvik Jain, Founding President of EnigmaMed Research Initiative, shared a post on X:
“In our latest publication in The Canadian Journal of Cardiology (CJC), we report risk of MACCE, AMI, and readmission in IBD patients undergoing PCI! Thanks to Andrew M. Goldsweig guidance and mentorship”
Title: Outcomes of Percutaneous Coronary Intervention in Patients with Inflammatory Bowel Disease: A Propensity-Score Matched Analysis
Authors: Hritvik Jain, Nandan Patel, Jyoti Jain, Kriti Soni, Siddharth P. Agrawal, Bala Pushparaji, Richard Malone, Mohammed Absar Ullah, Andrew M. Goldsweig
Read full article here.
Stay informed with Hemostasis Today.
-
Jun 15, 2026, 16:20New Therapeutic Strategies Targeting Iron Metabolism
-
Jun 15, 2026, 15:43Antonio Paul: Donor Safety Is More Than a Sterile Needle
-
Jun 15, 2026, 15:36Alejandro González Veliz: A Coronary Calcium Score of Zero Doesn’t Always Mean Zero Risk
-
Jun 15, 2026, 15:35Tareq Abadl: Your Blood Tells Your Story – Even in the Shape of Its Cells
-
Jun 15, 2026, 15:34Three Days of Learning, Collaboration, and Community at EHC 2026
-
Jun 15, 2026, 15:31Abdul Mannan: What if Our First Move in Acquired Haemophilia A is Costing Frail Patients Time?
-
Jun 15, 2026, 14:11Alba Maiques Diaz: Completion of My Tenure in the YoungEHA Committee at the EHA
-
Jun 15, 2026, 13:51Miguel Gómez Álvarez: Navigating the Complexities of Erythrocytosis and the Role of PIEZO1
-
Jun 15, 2026, 13:37Katja Sockel: EHA 2026 Inspires New Ideas and Global Connections